Stryker Corp. (NYSE:SYK) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $123.37 and last traded at $122.35, with a volume of 472,901 shares changing hands. The stock had previously closed at $122.82.

SYK has been the subject of a number of research reports. Goldman Sachs Group Inc. raised their price objective on shares of Stryker Corp. from $107.00 to $119.00 in a report on Friday, April 8th. Stifel Nicolaus raised their price objective on shares of Stryker Corp. from $92.00 to $105.00 and gave the company a “buy” rating in a report on Monday, March 28th. Canaccord Genuity raised their price objective on shares of Stryker Corp. from $76.00 to $82.00 and gave the company a “buy” rating in a report on Monday, March 28th. Brean Capital reiterated a “buy” rating on shares of Stryker Corp. in a report on Thursday, April 21st. Finally, Leerink Swann reiterated a “buy” rating and issued a $125.00 price objective (up previously from $111.00) on shares of Stryker Corp. in a report on Thursday, April 21st. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the company’s stock. Stryker Corp. presently has a consensus rating of “Hold” and an average target price of $109.23.

The stock has a market cap of $45.74 billion and a PE ratio of 28.62. The stock has a 50-day moving average price of $116.64 and a 200-day moving average price of $106.09.

Stryker Corp. (NYSE:SYK) last posted its quarterly earnings data on Wednesday, April 20th. The medical technology company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.20 by $0.04. During the same period last year, the business earned $1.11 EPS. The company earned $2.50 billion during the quarter, compared to the consensus estimate of $2.47 billion. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. On average, analysts anticipate that Stryker Corp. will post $5.77 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 29th. Stockholders of record on Thursday, June 30th will be paid a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 1.24%. The ex-dividend date is Tuesday, June 28th.

In other news, VP William E. Berry, Jr. sold 3,339 shares of the firm’s stock in a transaction dated Friday, April 22nd. The stock was sold at an average price of $109.23, for a total value of $364,718.97. Following the transaction, the vice president now owns 6,859 shares of the company’s stock, valued at $749,208.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronda E. Stryker sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $109.89, for a total value of $1,318,680.00. Following the completion of the transaction, the director now directly owns 193,142 shares in the company, valued at approximately $21,224,374.38. The disclosure for this sale can be found here.

Several hedge funds and institutional investors recently bought and sold shares of the company. Bank of Montreal Can increased its position in Stryker Corp. by 154.7% in the fourth quarter. Bank of Montreal Can now owns 777,488 shares of the medical technology company’s stock valued at $72,260,000 after buying an additional 472,237 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI increased its stake in shares of Stryker Corp. by 1.7% in the fourth quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 120,577 shares of the medical technology company’s stock valued at $11,206,000 after buying an additional 2,000 shares during the period. OppenheimerFunds Inc. increased its stake in shares of Stryker Corp. by 24.9% in the fourth quarter. OppenheimerFunds Inc. now owns 844,321 shares of the medical technology company’s stock valued at $78,480,000 after buying an additional 168,321 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of Stryker Corp. by 1.5% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 20,636 shares of the medical technology company’s stock valued at $1,918,000 after buying an additional 313 shares during the period. Finally, Commerzbank Aktiengesellschaft FI increased its stake in shares of Stryker Corp. by 96.1% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 27,640 shares of the medical technology company’s stock valued at $2,569,000 after buying an additional 13,545 shares during the period.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.